tiprankstipranks
Esperion Therapeutics (ESPR)
NASDAQ:ESPR
US Market
ESPR
Esperion
RESEARCH TOOLSreports
Want to see ESPR full AI Analyst Report?

Esperion (ESPR) Stock News & Sentiment

1,668 Followers
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk
Premium
Company Announcements
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk
20d ago
ESPR
EXE, IP, ESPR, CMPS, TNXP Trending With Analysts
Premium
Weekend Updates
EXE, IP, ESPR, CMPS, TNXP Trending With Analysts
20d ago
IP
EXE
ESPR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ESPR Earnings this Week: How Will it Perform?
24d ago
ESPR
AI Models Turn More Positive on Esperion as ARCHIMED Buyout Drives Upside
Premium
AI Analyst Ratings
AI Models Turn More Positive on Esperion as ARCHIMED Buyout Drives Upside
26d ago
ESPR
Esperion Stock Surges Onto Analysts’ Trending Radar
Premium
Weekend Updates
Esperion Stock Surges Onto Analysts’ Trending Radar
27d ago
ESPR
Esperion agrees to $1.1 billion ARCHIMED buyout
Premium
Company Announcements
Esperion agrees to $1.1 billion ARCHIMED buyout
28d ago
8K
ESPR
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
Premium
Ratings
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
2M ago
ESPR
More ESPR News >

ESPR News on the Web

Esperion presents new data from CLEAR Outcomes, CLEAR Phase 2 study
TipRanks News
Bullish
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
TipRanks News
Neutral
Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), PROCEPT BioRobotics (PRCT) and Vericel (VCEL)
TipRanks News
Bullish
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
TipRanks News
Neutral
Esperion, Athyrium Capital enter $50M royalty financing agreement
TipRanks News
Bullish
Esperion Therapeutics Earnings Call Signals Expansion
TipRanks News
Bullish
Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
ESPR
Sector Average
Media Buzz
This Week1 articles
Weekly Average4.5 articles
News Sentiment
This Week99%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ESPR’s Media Buzz Sentiment?
1 articles about ESPR were published this week. In an average week, 4.5 articles are published.
    What is ESPR’s weekly average amount of articles?
    In an average week, 4.5 articles about ESPR are published.
      What is ESPR’s News Sentiment?
      99% of articles about ESPR were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        AKTXAkari Therapeutics
        IMMXImmix Biopharma
        SYSo-Young International
        ADOAnteoTech Ltd
        FSPKFFisher & Paykel Healthcare Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week